Earnings Presentations
Apr 24, 2024
Feb 13, 2024
Nov 08, 2023
Jul 25, 2023
Apr 25, 2023
Feb 15, 2023
Investor R&D Day 2021
Sep 21, 2021
Sep 21, 2021
Sep 21, 2021
Sep 21, 2021
Sep 21, 2021
Sep 21, 2021
Sep 21, 2021
Sep 21, 2021
Sep 21, 2021
Sep 21, 2021
Conference and Other Investor Presentations
Jul 28, 2023
Dec 06, 2022
Jan 13, 2022
Jun 08, 2021
Oct 22, 2019
Jun 05, 2019
Mar 04, 2019
Dec 12, 2018
Jun 28, 2018
Medical and Scientific Conference Presentations
Mar 07, 2024
Interim Results From the Ongoing RESPOND Study of Nusinersen in Children With Spinal Muscular Atrophy Previously Treated With Onasemnogene Abeparvovec
View Presentation 532.3 KB
Oct 25, 2023
Exploratory Clinical Outcomes From the BIIB080 Phase 1b Multiple Ascending Dose and Long-term Extension Study in Mild Alzheimer’s Disease
View Presentation 828 KB
Jun 30, 2023
Jun 03, 2022
Evaluating Efficacy and Safety of Tofersen in Adults with SOD1-ALS: Results from the Phase 3 VALOR Trial and Open-Label Extension at ENCALS
View Presentation 2.4 MB
Mar 18, 2022
Evaluating the Evidence of Aducanumab Treatment Benefit Using Standardized Test Statistics and Global Statistical Tests at AD/PD
View Presentation 376.8 KB
Mar 18, 2022
Heterogeneity in Symptom Progression and Treatment Response: An Analysis of Participants with Early Alzheimer’s Disease from the EMERGE Aducanumab Trial at AD/PD
View Presentation 486 KB
Mar 18, 2022
Effect of Reduction in Brain β-Amyloid Levels on Cognitive Decline in Randomized Clinical Trials: An Updated Instrumental Variable Meta-Analysis at AD/PD
View Presentation 621.9 KB
Mar 18, 2022
Subgroup Analyses of the Plasma P-tau181 Population From EMERGE/ENGAGE, Phase 3 Clinical Trials Evaluating Aducanumab in Early Alzheimer’s Disease at AD/PD
View Presentation 649.7 KB
Mar 16, 2022
Mar 15, 2022
Aducanumab Phase 3 Studies: Exposure-Response Analysis Evaluating the Relationship Between Amyloid Removal and Slowing of Clinical Decline on CDR-SB Scores at AD/PD
View Presentation 183.2 KB
Annual Stockholder Presentation
June 15, 2022
Hemophilia Spin-off Presentations
January 6, 2017
May 3, 2016